Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00125970
First received: June 30, 2005
Last updated: November 7, 2012
Last verified: November 2012